Disclosures for "Predictors of Prognosis in Autoimmune/Paraneoplastic Cerebellar Ataxia: A Retrospective Cohort"
-
Miss Cerroni has nothing to disclose.
-
Dr. Hoshina has nothing to disclose.
-
Dr. Glenn has nothing to disclose.
-
Dr. Goel has nothing to disclose.
-
Miss Leles Vieira de Souza has nothing to disclose.
-
Dr. Mahler has received research support from The Sumaira Foundation.
-
The institution of Dr. Wruble has received research support from Alexion. The institution of Dr. Wruble has received research support from Roche.
-
Dr. Manzano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead Sciences. Dr. Manzano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for InfuCare Rx.